Stabilization of α-synuclein oligomers using formaldehyde

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Neurodegenerative diseases like Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are characterized by alpha-synuclein (α-syn) aggregates.
• Soluble α-syn oligomers are hypothesized intermediates in aggregation and potential biomarkers for synucleinopathies.
• The instability of α-syn oligomers prepared in vitro complicates research and biomarker development.

Purpose of the Study:

• To develop a method for stabilizing α-syn oligomers.
• To ensure stabilized oligomers retain their structural and antigenic properties.
• To validate the utility of stabilized oligomers as reliable standards in biomarker assays.

Main Methods:

• Utilized formaldehyde (FA), a small amine-reactive cross-linker, to stabilize α-syn oligomers.
• Assessed the size, overall structure, and antigenicity of cross-linked oligomers using specific antibodies (FILA, MJFR-14-6-4-2).
• Evaluated the stability of cross-linked oligomers against denaturants (urea, SDS) and their functionality as internal standards in ELISA.

Main Results:

• Formaldehyde successfully stabilized α-syn oligomers without altering their size, structure, or antigenicity.
• Cross-linked α-syn oligomers demonstrated resistance to urea and SDS treatment.
• Stabilized oligomers remained functional as internal standards in aggregation-specific ELISA, even after urea exposure.

Conclusions:

• FA-cross-linked α-syn oligomers provide a stable and reliable format for research.
• These stabilized oligomers can serve as crucial calibrators for standardized biomarker studies in synucleinopathies.
• This stabilization method facilitates comparative analysis and enhances the accuracy of α-syn biomarker quantification.